MedPath

湖北成健药业有限公司

Ownership
-
Established
2022-12-07
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Isosorbide Dinitrate Sustained-release Tablets

Product Name
硝酸异山梨酯缓释片
Approval Number
国药准字H45021137
Approval Date
Aug 23, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.